![]() |
市场调查报告书
商品编码
1479979
分子诊断的全球市场,预测到 2029 年Global Molecular Diagnostics Market, Forecast to 2029 |
分子诊断激发成长机会并推动创新的个人化医疗
由于多种因素,包括 COVID-19 大流行导致的需求增加、癌症病例数量增加以及技术力的快速发展,全球分子诊断市场预计将显着增长。
聚合酵素链锁反应(PCR)、数位 PCR 和次世代定序(NGS) 等技术的进步提高了分子检测的准确性和生产力,并实现了个人化治疗。
预测分析按区域和应用程式进行细分。后者包括传染病检查、肿瘤学检测、基因检测和其他分子诊断。由于方法上的限制,Frost & Sullivan对该行业的预测采用定性方法进行成长机会分析。
癌症发生率的增加加速了对先进分子诊断工具的需求,而慢性病的增加、政府医疗保健的现代化以及对个人化医疗的需求不断增加将推动分子诊断行业的显着增长。集中的医疗监管和强大的研发投资将促进这一扩张。
Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine
The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities.
Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment.
The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan's forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints.
The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.